Corporate Governance Report not applicable for Sep 2026 quarter
CURIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Curis Lifesciences has informed NSE that the quarterly Corporate Governance Report under SEBI Regulation 27(2) does not apply to it for the quarter and half year ended September 30, 2026. Since the company is listed on the NSE SME platform (NSE Emerge), it is exempt from most corporate governance provisions under Regulation 15(2)(b). A certificate from a practicing company secretary has been attached. This is a routine compliance filing.
No material impact on shareholders. Routine regulatory clarification due to SME listing status; no change in operations or financials.